0001526335-15-000002.txt : 20150619 0001526335-15-000002.hdr.sgml : 20150619 20150619095122 ACCESSION NUMBER: 0001526335-15-000002 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150617 FILED AS OF DATE: 20150619 DATE AS OF CHANGE: 20150619 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARGOS THERAPEUTICS INC CENTRAL INDEX KEY: 0001105533 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 562110007 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4233 TECHNOLOGY DR CITY: DURHAM STATE: NC ZIP: 27704 BUSINESS PHONE: 9192876300 MAIL ADDRESS: STREET 1: 4233 TECHNOLOGY DR CITY: DURHAM STATE: NC ZIP: 27704 FORMER COMPANY: FORMER CONFORMED NAME: MERIX BIOSCIENCE INC DATE OF NAME CHANGE: 20000207 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Underdown Brian J. CENTRAL INDEX KEY: 0001526335 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-35443 FILM NUMBER: 15941526 MAIL ADDRESS: STREET 1: C/O LUMIRA CAPITAL INVESTMENT MANAGEMENT STREET 2: 141 ADELAIDE ST. WEST, SUITE 770 CITY: TORONTO ONTARIO CANADA M5H 3L5 STATE: A6 ZIP: 00000 4/A 1 primary_doc.xml PRIMARY DOCUMENT X0306 4/A 2015-06-17 2015-06-18 0 0001105533 ARGOS THERAPEUTICS INC ARGS 0001526335 Underdown Brian J. C/O LUMIRA CAPITAL INVESTMENT MANAGEMENT 141 ADELAIDE ST. WEST, SUITE 770 TORONTO ONTARIO CANADA M5H 3L5 A6 00000 ONTARIO, CANADA 1 0 0 0 Stock Option (right to buy) 7.8 2015-06-17 4 A 0 5500 0 A 2025-06-16 Common Stock 5500 5500 D This option was granted on June 17, 2015 and vests in equal amounts quarterly over the 12 month period beginning June 17, 2015. Lori R. Harrelson, as attorney-in-fact 2015-06-19